Tech Company Financing Transactions
Tenpoint Therapeutics Funding Round
Tenpoint Therapeutics, based in Cambridge, England, raised $70 million from British Patient Capital, Eight Roads and F-Prime Capital.
Transaction Overview
Company Name
Announced On
7/13/2023
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to develop its regenerative medicine platform to replace multiple cell types lost to inherited and age-related conditions.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 Broad Street, Great Cambourne
Cambridge, England, CB23 6HJ
UK
Cambridge, England, CB23 6HJ
UK
Phone
Undisclosed
Website
Email Address
Overview
We are developing engineered cell-based therapeutics and in vivo reprogramming to reverse vision loss caused by deterioration of functional tissue.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eddy Anglade
Chief Technical Officer
Gabriella Rolli
Founder
Pete Coffey
Founder
Thomas Reh
Browse more venture capital transactions:
Prev: 7/13/2023: Efficient Capital Labs venture capital transaction
Next: 7/13/2023: Wastefront venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs